NEW JERSEY (WABC) -- While the push is on to get more of the COVID-19 vaccine, there is some hope on the horizon. Johnson & Johnson is getting closer to seeking emergency FDA approval for its vaccine ...

NEW BRUNSWICK, N.J. -- A real-world study of South African health care workers found that two doses of the Johnson & Johnson COVID-19 vaccine offer 85% protection against hospitalization from the ...

A top doctor is pushing back against a panel of experts' decision to delay voting on a recommendation to give to the Centers for Disease Control and Prevention regarding the Johnson & Johnson COVID-19 ...

The FDA gave an emergency use authorization of a one-shot coronavirus vaccine by Johnson & Johnson on Saturday, marking the third coronavirus shot allowed to be administered to Americans. Johnson and ...

Results from early stage trials of Johnson & Johnson’s COVID-19 vaccine are promising, showing the one-dose vaccine generates an immune response in nearly all volunteers, with minimal side effects.

Johnson & Johnson has paused its COVID-19 vaccine study because one of its participants was taken ill. The 60,000-patient clinical trial met the criteria for a “pausing rule,” reported Stat News, ...

Johnson & Johnson says its single-shot COVID-19 vaccine is effective in preventing severe cases of COVID-19, but not as well as other two-shot variants of the vaccine that are already on the market.

The rollout of the Johnson & Johnson vaccine against COVID-19 will remain on pause for at least a week. The Centers for Disease Control and Prevention says it needs more time to study a link between ...